Ocean Biomedical (OCEA) went public via a SPAC merger with Aesther Healthcare Acquisition Corp. Ocean Biomedical helps with the development and commercialization of medical treatments from research universities and medical centers. The company is currently developing treatments for malaria, lung cancer, brain cancer, and pulmonary fibrosis. Founder and executive chairman Chirinjeev Kathuria discusses OCEA going public on the Nasdaq.
21 Feb 2023